期刊文献+

Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43 被引量:1

原文传递
导出
摘要 Background:In our previous paper,we demonstrated that Connexin 43(CX43)was highly expressed in bladder cancer(BC)tissues.But the molecular mechanism about microRNAs(miRNAs)regulation upstream of CX43 in BC has not been well elucidated and remains to be further studied.MicroRNA-139-5p(miR-139-5p)is a tumor suppressor in progression of multifarious cancers including BC.Nevertheless,the underlying mechanisms of CX43/miR-139-5p in tumorigenesis of BC are still not well illustrated.The specific objective of our study was to inquiry the effect of CX43/miR-139-5p on BC progression and its underlying mechanism.Methods:The bioinformatics analysis softwares were applied to predict the miRNAs in the upstream of CX43.First,the expression levels of miR-139-5p in BC tissues(tumor)and paracancer tissues(normal)were investigated using the data from The Cancer Genome Atlas database.Quantitative reverse transcription-polymerase chain reaction(qRT-PCR)was used to detect the mRNA expression level of miR-139-5p in three human BC cell lines 5637,T24,ECV-304 and a human bladder epithelial immortalized cell line SV-HUC-1(normal control).Then si-CX43,si-control,miR-139-5p mimic,and its negative control(NC)were transfected into BC cell line ECV-304.The relationship of miR-139-5p and CX43 was analyzed by dual-luciferase reporter assay.The qRT-PCR and Western blotting were used to test the mRNA and protein expression level of CX43.The proliferation of ECV-304 and T24 cells were examined by cell counting kit-8.The migration and invasion of ECV-304 cells were tested by transwell assay.To determine whether miR-139-5p would affect cell proliferation,migration and invasion by targeting CX43,we executed the rescue assay.The comparison between two groups was analyzed by Student’s t test,and comparisons among multiple samples were performed by oneway analysis of variance and a Bonferroni post hoc test.Results:The expression of miR-139-5p was remarkably down-regulated in BC tissues(tumor vs.normal,2.286±0.017 vs.3.211±0.034,t=11.540,P<0.0001)and cell lines(P<0.01 in all BC cell lines).Besides,we also indicated that over-expression of miR-139-5p reduced the proliferation of ECV-304(P=0.001)and T24 cells(P=0.005).Moreover,miR-139-5p over-expression weakened the invasion(P=0.001)and migration(P=0.001)of ECV-304 cells.Furthermore,the relative luciferase activity of CX43-wild type construct was distinctly lessened by up-regulation of miR-139-5p(miR-139-5p mimic NC vs.miR-139-5p mimic,0.916±0.063 vs.0.356±0.048,t=7.085,P=0.002),nevertheless the activity of CX43-mutant type construct was untouched(miR-139-5p mimic NC vs.miR-139-5p mimic,0.918±0.057 vs.0.878±0.039,t=0.577,P=0.595).Finally,the rescue assay revealed that CX43 deletion enhanced the depressor effect of miR-139-5p on ECV-304 cell proliferation(P<0.01),invasion(P=0.028),and migration(P=0.014).Conclusion:MiR-139-5p,as a tumor-suppressor,repressed cell proliferation,invasion,and migration in BC,which might be achieved by regulating CX43.
机构地区 Department of Urology
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2019年第19期2354-2361,共8页 中华医学杂志(英文版)
  • 相关文献

参考文献1

二级参考文献28

  • 1Coughlin SS, Ekwueme DU. Breast cancer as a global health concern. Cancer Epidemiol 2009;33:315-8. doi: 10.1016/j. canep. 2009. l 0.003.
  • 2Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biornarkers Prev 2010;19:1893-907. doi: 10.1158/1055-9965.
  • 3Lin SX, Chen J, Mazumdar M, Poirier D, Wang C, Azzi A, et al. Molecular therapy of breast cancer: Progress and future directions. Nat Rev Endocrinol 2010;6:485-93. doi: 10.1038/nrendo.2010.92.
  • 4Conklin CM, Bechberger JF, MacFabe D, Guthrie N, Kurowska EM, Naus CC. Genistein and quercetin increase connexin43 and suppress growth of breast cancer cells. Carcinogenesis 2007;28:93-100. doi: 10.1093/carcirl/bgl 106.
  • 5Park SY, Lee HE, Li H, Shipitsin M, Gelman R, Polyak K. Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Clin Cancer Res 2010;16:876-87. doi: 10.1158/1078-0432.
  • 6Elzarrad MK, Haroon A, Willecke K, Dobrowolski R, Gillespie MN, A1-Mehdi AB. Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium. BMC Med 2008;6:20. doi: 10.1186/1741-7015-6-20.
  • 7Kanczuga-Koda L, Sulkowski S, Lenczewski A, Koda M, Wincewicz A, Baltaziak M, et al. Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer. J Clin Pathol 2006;59:429-33. doi: 10.1136/jcp.2005.029272.
  • 8Petri A, Lindow M, Kauppinen S. MicroRNA silencing in primates: Towards development of novel therapeutics. Cancer Res 2009;69:393-5. doi: 10.1158/0008-5472.
  • 9Zhang H, Li Y, Lai M. The microRNA network and tumor metastasis. Oncogene 2010;29:937-48. doi: 10.1038/onc.2009.406.
  • 10Jovanovic M, Hengartner MO. miRNAs and apoptosis: RNAs to die for. Oncogene 2006;25:6176-87. doi: 10.1038/ sj.onc.1209912.

同被引文献3

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部